FDA Recalls Prescription Lidocaine Patch Due to Temperature Exposure
McKesson Medical-Surgical is recalling Lidocaine Patch 5% nationwide due to temperature abuse during distribution that may have compromised product quality. The FDA classified this as a Class II recall.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard involves a manufacturing deviation (temperature exposure) during distribution, which is precautionary in nature and does not represent a direct threat to patient safety.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Lidocaine Patch 5% (Rx only) manufactured by Qualitest Products. The recall affects product distributed nationwide across the United States.
The FDA classified this as a Class II recall due to cGMP deviations involving temperature abuse during distribution. Temperature exposure may have affected the product's integrity and quality.
No illnesses or injuries have been reported in connection with this recall. Patients and healthcare providers should contact McKesson Medical-Surgical or their healthcare provider with questions about affected product.
The recalled product
- Product
- LIDOCAINE (LIDOCAINE)
- Brand
- LIDOCAINE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Hazard
- temperature-abuse
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE
- HighPrescription Lidocaine Injection Recalled for Cracked Cartridge Defect
FDA (Drugs) · 2025-12-24
- ModerateLidocaine Patch 5% Recalled for Typographical Error on Label
FDA (Drugs) · 2023-05-10
- ModeratePrescription Lidocaine Patches Recalled for Temperature-Related Quality Deviations
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27